PEAK6 Investments’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$511K Buy
10,000
+2,000
+25% +$102K ﹤0.01% 430
2024
Q2
$358K Buy
+8,000
New +$358K ﹤0.01% 513